Researchers Identify “Male Contraceptive Pill” That Stops Sperm Without Affecting Hormones.

Researchers Identify “Male Contraceptive Pill” That Stops Sperm Without Affecting Hormones.
admin
Researchers have identified a compound which turns off the sperm’s ability to swim, thereby significantly limiting fertilisation capabilities without causing any physical side effects. The compound called EP055 affects the mobility of sperm, and was successful in tests with monkeys, suggesting a “male contraceptive pill” could be on the way. In a study with monkeys, researchers found EP055 binds to sperm proteins and slows their mobility. The findings were published on Friday in the journal PLOS ONE. Currently, condoms and surgical vasectomy are the only safe forms of birth control currently available for men.
Scientists Develop Male Contraceptive Pill – Say It Does Not Harm Sex Drive
There are hormonal drugs in clinical trials that target the production of sperm, but these affect the natural hormones in men much like female contraceptives affect hormones in women. During the study, 30 hours following a high-dose intravenous infusion of EP055 in male monkeys, the researchers found no indication of normal sperm motility. Further, no physical side effects were observed.
“At 18 days post-infusion, all macaques showed signs of complete recovery,” said study co-investigator Mary Zelinski from Oregon National Primate Research Center at Oregon Health and Science University in the US. “Simply put, the compound turns-off the sperm’s ability to swim, significantly limiting fertilization capabilities,” said lead investigator Michael O’Rand, a retired professor in University of North Carolina at Chapel Hill School of Medicine and President/CEO of Eppin Pharma Inc.
“This makes EP055 an ideal candidate for non-hormonal male contraception,” O’Rand added.

0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

Recruitment

HR

Duties and Responsibilities
1. Communicate product information in a way that's meaningful and relevant to each individual customer and account; customize discussions and client interactions based on understanding of customer's needs
2. Maintain effective communication and relationships with key external and internal customers.
3. Within institutional hospital accounts, act as primary point of contact for customer, meets with key customers/personnel to understand practice structure, business model, key influencers /network structure, customer needs and identifies business opportunities
4. Promote DKT Nigeria products and services to physicians and other medical personnel within assigned geography
5. Demonstrate advanced ability to ask strategic, insightful questions to obtain information on specific customer business/ healthcare needs. Uses the insights to position DKT Nigeria’s products and collaborates with customers on focused and customized business strategy
6. Share learnings and best-practices from one customer to help other customers meet their needs and exhibit professionalism and leadership with clients/ key account clinics
7. Build strategic relationships with the key opinion leaders in hospitals and clinics to negotiate purchases.
8. Engage in all job responsibilities and activities with the highest standards of ethics and integrity, with emphasis on compliance with all relevant laws, policies and regulations.
9. Additional duties as needed

Qualification/Experience- The candidate must have the following:
• Three to five years’ experience in clinic key account management / institutional sales of pharmaceutical products
• Flexibility to adapt to changing priorities and to work as part of a team
• Exceptional verbal, written and presentation skills
• Competency in Microsoft applications including Word, Excel, and PowerPoint
• Well-organized, with ability to track multiple activities and deadlines
The position reports to the Institutional Clinical Manager.
Interested and qualified candidates should send their CV with subject tagged, Institutional Clinical Representative (Location) to hr@dktnigeria.org

Application deadline: 30 November 2019